MIRAGEN THERAPEUTICS, INC. (53) | Intellectual Property (3)
Browse by Subcategory
Recent Contracts
-
Technology License Agreement, by and between the Registrant and Xencor, Inc., dated as of December 16, 2020
(Filed With SEC on March 26, 2021)
-
License Agreement, by and between the Company and ImmunoGen, dated as of October 12, 2020
(Filed With SEC on December 9, 2020)
-
Amendment No. 1 to Amended and Restated License Agreement, effective as of August 8, 2019, by and between Registrant and Roche Innovation Center Copenhagen A/S
(Filed With SEC on November 8, 2019)